Siemens is reviewing a large part of Healtieers, CFO tells Handelsblatt via Reuters
MUNICH (Reuters) – Siemens AG (OTC:) is revising its majority stake in medical technology subsidiary Siemens (ETR:) Healthineers, the German technology group’s Chief Financial Officer Ralf Thomas told Handelsblatt newspaper.
The partnership with the manufacturer of MRI machines and laboratory systems is not big enough to justify a commitment of 45 billion euros ($46.91 billion), Thomas told Handelsblatt, referring to how much Siemens’ 75% of the equity is.
“We are evaluating the economic opportunities of Siemens AG in the healthcare sector. We will then find out from this how Healpineers is useful as an investment. Then we will reach a conclusion on that,” he said, adding that the results will be presented. on the day of the capital markets at the end of 2025.
Siemens AG spun off its Erlangen, Germany-based subsidiary in 2018 and put it in stock. Until now, Siemens has maintained that it will retain a majority stake in Siemens Healthineers.
However, Thomas recently expressed the hope of selling about 5% in the future to finance the takeover of American software company Altair.
Thomas said he is still committed to the Mobility train division, which investors have repeatedly called for it to be liquidated.
“The business is in good hands with us. I don’t see the need to part with it right now,” he told Handelsblatt.
($1 = 0.9592 euros)
